Showing results (141-150 of 179) with videos related to

Sort By:
Pageof 18
British Journal of Pharmacology|October 12, 1999
Block of human aorta Kir6.1 by the vascular KATP channel inhibitor U37883AS Surah-Narwal, S Z Xu, D McHugh, et al.
British Journal of Pharmacology|August 26, 2010
Cis-isomerism and other chemical requirements of steroidal agonists and partial agonists acting at TRPM3 channelsY Majeed, A K Agarwal, J Naylor, et al.
Surgery|June 17, 1998
Locally recurrent soft tissue sarcoma of the extremitiesG P Midis, R E Pollock, N P Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcomaJ Yao, R E Pollock, A Lang, et al.
British Journal of Pharmacology|January 22, 2008
Modulation of TRPC5 cation channels by halothane, chloroform and propofolY M Bahnasi, H M Wright, C J Milligan, et al.
Surgery|September 1, 1994
Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experienceH Gutman, R E Pollock, M I Ross, et al.
Archives of Otolaryngology--Head & Neck Surgery|March 18, 2000
PH20: a novel tumor marker for laryngeal cancerD A Godin, P C Fitzpatrick, A B Scandurro, et al.
Cancer|October 3, 2000
Primary treatment of cystosarcoma phyllodes of the breastA W Chaney, A Pollack, M D McNeese, et al.
Annals of Surgery|April 1, 1990
Preoperative chemotherapy for soft-tissue sarcomas of the extremitiesC M Pezzi, R E Pollock, H L Evans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 30, 1999
Role of radiotherapy in sarcoma of the breast--a retrospective review of the M.D. Anderson experienceB J Barrow, N A Janjan, H Gutman, et al.
Pageof 18